Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels

Journal of Molecular Medicine

Volumn 91, Issue 11, 2013, Pages 1285-1292

  Breitfeld, Jana ^a   Heiker, John T ^a   Böttcher, Yvonne ^a   Schleinitz, Dorit ^a   Tönjes, Anke ^a   Weidle, Kerstin ^a   Krause, Kerstin ^a   Kuettner, E Bartholomeus ^a   Scholz, Markus ^a   Kiess, Wieland ^a   Sträter, Norbert ^a   Beck Sickinger, Annette G ^a   Stumvoll, Michael ^a   Körner, Antje ^a   Blüher, Matthias ^a   Kovacs, Peter ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Rs61757459; SerpinA12; Serum vaspin; Vaspin

Indexed keywords

VASPIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CRYSTAL STRUCTURE; ESCHERICHIA COLI; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STOP CODON;

AGED; CODON, TERMINATOR; COHORT STUDIES; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; MUTATION; PHYLOGENY; PROTEIN FOLDING; PROTEIN STABILITY; RECOMBINANT PROTEINS; SERPINS;

EID: 84888638773     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-013-1062-9     Document Type: Article

References (25)

1. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A et al (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci 102(30):10610-10615
2. Wada J (2008) Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17(3):327-333
3. Youn B, Klöting N, Kratzsch J, Lee N, Park JW, Song E, Ruschke K, Oberbach A, Fasshauer M, Stumvoll M et al (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57(2):372-377
4. Heiker JT, Klöting N, Kovacs P, Küttner EB, Sträter N, Schultz S, Kern M, Stumvoll M, Blüher M, Beck-Sickinger AG (2013) Vaspin inhibits kallikrein 7 by serpin mechanism. Cell Mol Life Sci. doi: 10.1007/s00018-013-1258-8
5. Breitfeld J, Tönjes A, Böttcher Y, Schleinitz D, Wiele N, Marzi C, Brockhaus C, Rathmann W, Huth C, Grallert H et al (2012) Genetic variation in the vaspin gene affects circulating serum vaspin concentrations. Int J Obes (Lond). doi: 10.1038/ijo.2012.133
6. Kempf K, Rose B, Illig T, Rathmann W, Strassburger K, Thorand B, Meisinger C, Wichmann H, Herder C, Vollmert C (2010) Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: results from the MONICA/KORA studies. Exp Clin Endocrinol Diabet 118(03):184-189
7. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42(2):105-116
8. Saxena R, Hivert M, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU et al (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 42(2):142-148
9. Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, Bouatia-Naji N, Langenberg C, Prokopenko I, Stolerman E et al (2010) Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways. Diabetes 59(12):3229-3239
10. Tönjes A, Koriath M, Schleinitz D, Dietrich K, Böttcher Y, Rayner NW, Almgren P, Enigk B, Richter O, Rohm S et al (2009) Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs. Hum Mol Genet 18(23):4662-4668
11. Tönjes A, Zeggini E, Kovacs P, Böttcher Y, Schleinitz D, Dietrich K, Morris AP, Enigk B, Rayner NW, Koriath M et al (2010) Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany. Eur J Hum Genet 18(1):104-110
12. Veeramah KR, Tönjes A, Kovacs P, Gross A, Wegmann D, Geary P, Gasperikova D, Klimes I, Scholz M, Novembre J et al (2011) Genetic variation in the Sorbs of eastern Germany in the context of broader European genetic diversity. Eur J Hum Genet 19(9):995-1001
13. ADA (2009) Standards of medical care in diabetes-2010. Diabetes Care 33 (Supplement-1): S11-S61
14. Böttcher Y, Teupser D, Enigk B, Berndt J, Klöting N, Schön MR, Thiery J, Blüher M, Stumvoll M, Kovacs P (2006) Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab 91(7):2725-2731
15. Körner A, Ma L, Franks PW, Kiess W, Baier LJ, Stumvoll M, Kovacs P (2007) Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children. Int J Obes (Lond) 31(2):353-358
16. Körner A, Neef M, Friebe D, Erbs S, Kratzsch J, Dittrich K, Blüher S, Kapellen TM, Kovacs P, Stumvoll M et al (2010) Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 35(4):578-586
17. Yang Z (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24(8):1586-1591
18. Scholz M, Kirsten H (2011) Comparison of scoring methods for the detection of causal genes with or without rare variants. BMC Proc 5(Suppl 9):S49
19. Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A et al (2012) Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 97(7):E1202. doi: 10.1210/jc.2011-3297
20. Jeong E, Youn BS, Kim DW, Kim EH, Park JW, Namkoong C, Jeong JY, Yoon SY, Park JY, Lee KU et al (2010) Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals. J Clin Endocrinol Metab 95(4):1869-1875
21. Kovacs P, Miehle K, Sandner B, Stumvoll M, Bluher M (2013) Insulin administration acutely decreases vaspin serum concentrations in humans. Obes Facts. doi: 10.1159/000348836
22. Klöting N, Kovacs P, Kern M, Heiker JT, Fasshauer M, Schön MR, Stumvoll M, Beck-Sickinger AG, Blüher M (2011) Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54(7):1819-1823
23. Breitfeld J, Tönjes A, Gast M, Schleinitz D, Blüher M, Stumvoll M, Kovacs P, Böttcher Y (2013) Role of vaspin in human eating behaviour. PLoS One. doi: 10.1371/journal.pone.0054140
24. Ng PC, Henikoff S (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31(13):3812-3814
25. Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A et al (2012) Vaspin Is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex. Diabetes 61(11):2823-2832